BUZZ-Australia's <a href="https://laohu8.com/S/MEM.AU">Memphasys</a> jumps on European regulatory approval for product** Shares of Memphasys MEM.AX rise as much as 60% to A$0.008, their highest level since April 3
** Stock set for strongest trading session since September 8, if current trends hold
** Biotech co granted Conformité Européenne $(CE)$ mark approval for its Felix automated sperm selection system
** CE Mark confirms that Felix complies with the European Union Medical Device Regulation - co
** Around 43.4 mln shares change hands, 7.5x the 30-day avg volume
** YTD, stock up 5%, including the day's moves
(Reporting by Shivangi Lahiri in Bengaluru)
((shivangi.lahiri@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.